Member Info for SestionLad

Thanks Joeman1 here’s hoping

That trade at 16.25 was a buy. It was my buy.

Fri, 1st May 2020 13:34

RNS Number : 6970L
ValiRx PLC
01 May 2020







VALIRX PLC

("ValiRx", the "Company" or the "Group")



Share Price Movement



London, UK., 1 May 2020: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company notes the recent movement in its share price.



The Company notes that there has been a significant amount of corporate and clinical activity notified in the past 2 weeks.



As announced on 1 April 2020 the Company is required to raise further funds in the near future in order to meet its working capital requirements. In the event that the Company undertakes a placing it is likely to be at a significant discount to the Company's current share price.



This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Wed, 29th Apr 2020 17:42

RNS Number : 3894L
ValiRx PLC
29 April 2020

VALIRX PLC

("ValiRx", the "Company" or the "Group")



Statement re social media reports



London, UK., 29 April 2020: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company, notes the recent movement in the Company's share price and speculative comments posted on social media in respect of a potential Joint Venture in relation to the Company's non-core intellectual property - GeneICE, TRAC and BioFit.



The Company confirms that it is in talks with a third-party in relation to a Joint Venture. However, there is no certainty the talks will conclude in a successful manner, nor that in the event that the Joint Venture is agreed, that the terms will be favourable to the Company.



-ENDS-



This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

14 April 2020
ValiRx Plc
("ValiRx" or the "Company")
Change of Director

London, UK, 14 April 2020: ValiRx Plc (AIM: VAL), a clinical stage biotechnology company, announces George Morris has tendered his notice as a director of the Company which has been accepted by the board, therefore George Morris is no longer a director of the Company.



This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Total Voting Rights
The share capital reorganisation will become effective on or around 6 April 2020 when it is expected that admission of the 12,278,618 consolidated share capital of the Company will be admitted to trading on AIM.

The Company's issued share capital will comprise 12,278,618 ordinary shares of 0.1p each with voting rights. The Company does not hold any shares in treasury. This figure 12,278,618 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.


This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.


For more information, please contact:

ValiRx plc
Tel: +44 (0) 20 3008 4416
www.valirx.com
Dr Satu Vainikka, Chief Executive
Tel: +44 (0) 20 3008 4416
Tarquin Edwards, Head of Communications.
Tel: +44 (0) 7879 458 364
tarquin.edwards@valirx.com

Cairn Financial Advisers LLP (Nominated Adviser)
Liam Murray / Jo Turner / Ludovico Lazzaretti

Tel: +44 (0) 20 7213 0880

RNS Number : 4204I
ValiRx PLC
01 April 2020

1 April 2020
ValiRx Plc
("ValiRx" or the "Company")
Result of General Meeting

London, UK, 1 April 2020: ValiRx Plc (AIM: VAL), a clinical stage biotechnology company, announces the reconvening of the General Meeting that was adjourned on 25 March 2020 and the Result of the General Meeting.

Reconvening of General Meeting

The Company adjourned its General Meeting to be held on 25 March 2020 as a result of the COVID-19 situation. However, in the light of the availability of the Conditional Placing, the Board has concluded that their fiduciary duties to stakeholders including the creditors and shareholders of the Company required that the General Meeting should be reconvened as a matter of urgency.

The COVID-19 lockdown makes attendance of shareholders at the meeting impossible and the Board has been unable to find a suitable means of shareholders participating and voting during the lockdown.

The Board note that the shareholders have had the opportunity to vote their shares by proxy.

The Board regards its obligations to its shareholders and creditors as overriding any procedural difficulties that there may be in holding a meeting during the COVID-19 lockdown.

The Company announced on 25 March 2020 that 7 days' notice of the reconvening of the meeting would be required but given both the urgency of the financial situation and the fact that shareholders would not be able to attend and vote at any reconvened meeting because of the COVID-19 lockdown, the Board has decided to allow the proceedings to be decided on a poll based upon the proxies received for the General Meeting at its originally scheduled time.

Accordingly, the Board today reconvened the meeting with certain directors (who are also shareholders) present.

The Board regret that shareholders were unable to attend in person due to the COVID-19 situation but by deciding the resolutions on a poll, the Board believe shareholders are being treated as fairly as possible in the circumstances. To act otherwise would be to disenfranchise those that voted by proxy prior to the COVID-19 lockdown. The Board notes that attendance at shareholders meetings by shareholders who have not already voted by proxy has historically been low.



Result of General Meeting

Resolutions 1 (Ordinary Resolution - share capital reorganisation) and Resolution 2 (Ordinary Resolution - General Authority to issue shares) were passed.

Resolution 3 (Special Resolution - disapplication of pre-emptive rights) did not pass.

The poll results are set out below:-

Resolutions

For

Against

Discretion

Resolution 1

198,742,919

25,741,867

19,868,944

Resolution 2

199,309,669

24,740,401

19,868,944

Resolution 3

158,156,997

60,821,243

19,963,044



Total Voting Rights
The share capital reorganisation will become effective on or around 6 April 2020 when it is expected that admission of the 12,278,61

Thanks for your great advice. I will sell all of my holding as soon as markets open.

RNS Number : 6050C
AIM
11 February 2020

NOTICE

11/02/2020 7:45am

TEMPORARY SUSPENSION OF TRADING ON AIM

EURASIA MINING PLC

Trading on AIM for the under-mentioned securities has been temporarily suspended from 11/02/2020 7:45am pending an announcement.

ORDINARY SHARES OF 0.1P EACH, FULLY PAID (0323042) (GB0003230421)

If you have any queries relating to the above, please contact London Stock Exchange on +44 (0)161 832 2174.

How do you know that PoC?

Thanks Paddygall

Maybe, just maybe this deal will be good for us. It’s probably the best offer made given the current situation we find ourself in following the dusters. We may just get to see what’s in the Paleozoic if drilling does go ahead and it may just be the monster that Brian reckons it is. Let’s wait until the details are announced to see how good or bad it really is for us. Maybe we might just get the chance to party in the paleozoic!! Love to see those 6TCFs stuffed under Brian’s belt

Any idea when we can expect a further update from Newcrest regarding Havieron? I know they have just had their AGM but nothing new has come from it. Thanks
Sestion

Well said Koozer. How long you been in this share or are you a newbie who only registered today?

You are right JOHN11223344. I don’t recall seeing you getting angry at 20p. Why was that? NoW you are telling us that we should have been getting angry then and not now.

Luke, I asked the company the same question regarding the Paleozoic and received the following response: “Slide 6 of the Q1 2019 presentation illustrates an interpretation of the TE-10 well result that we have to date. At present we have determined from the wellsite palynology that we have a TAGI sequence of Rhartian to Late Carnian (Triassic) in age. In the lower section of the well the wellsite palynological ages are indeterminate, however, we are currently interpreting this lower section as potentially Permian in age. The Permian is a period within the Palaeozoic era. Further analysis of the cuttings data will be required to confirm this interpretation of preserved Permian in TE-10, this work is on-going. Incidentally, the TE-8 well also has a Permian section (dated through post-well palynological analyses) preserved beneath the TAGI sequence..”

Jambo it looks like a Bed and ISA of £20k

Thought this was a bulletin board for the company known as SOUND ENERGY, not BREXIT.

Please keep your Brexit comments to yourselves or on other chat forums. Not here!!

Fingers crossed. Should be a positive reaction on the SP today

Does anyone think that the major who walked may potentially be back now that clarity has been given by the government? This may have been a factor for them walking.